Suprasorb® CNPendo Used for Negative Pressure Therapy in the Oesophagus and Rectum to Support Defect and Wound Healing — Velox  

Esophagus Injury Clinical Trial

Official title: A Post-Market Clinical Follow-up (PMCF) Study Designed as Non-interventional, Observational, Prospective, Multicentre Study in a Routine Clinical Care Setting Using a Marketed Medical Device in Line With the Corresponding Instruction for Use (IFU) in the Intended Patient Population

Status Not yet recruiting

Clinical Trial Summary

A Post-Market Clinical Follow-up (PMCF) study designed as non-interventional, observational, prospective, multicentre study in a routine clinical care setting using a marketed medical device in line with the corresponding Instruction for Use (IFU) in the intended patient population. Patients will be diagnosed and evaluated for eligibility in routine clinical care by expert centres in the indication of interest. They will be consecutively enrolled into the study provided that all inclusion and exclusion criteria are met and written consent is given to use their clinical routine data according to data privacy regulations. The study protocol does not define specific study procedures for patients enrolled. Therapies and procedures during the course of this study will be performed according to the decision of the treating physician based on current applicable medical guidelines and on local policy in clinical routine care.

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Esophagus Injury
• Rectal Lesion

• NCT number: NCT05476263
• Study type: Observational [Patient Registry]
• Source: Lohmann & Rauscher
• Contact: Daria Trofimenko, MD
• Phone: +49 (0)2631- 99 6385
• Email: Daria.Trofimenko@de.LRmed.com
• Status: Not yet recruiting
• Start date: January 1, 2023
• Completion date: January 1, 2026